Drug intelligence / Profile preview

TCM formula

Development stage
Unknown
Lead developer
China Medical University Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

A Traditional Chinese Medicine (TCM) formulation developed by China Medical University Hospital specifically for the prophylactic treatment of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) related dermatological adverse effects. It is primarily indicated for patients with advanced non-small cell lung cancer (NSCLC) who are at risk of developing acneiform dermatitis or rash while receiving therapies such as afatinib, erlotinib, or gefitinib. The formula is designed to reduce the incidence of grade 3 skin toxicities and delay the onset of symptoms, thereby improving patient quality of life and preventing the need for EGFR-TKI dose reduction or discontinuation. The preparation is based on TCM syndrome differentiation and clinical experience, aiming to provide a synergic effect with standard cancer therapies without interference.

Other names
Prophylactic TCM for EGFR-TKI Related Skin ToxicityTCM Formula

Beyond the preview

Go deeper on TCM formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TCM formula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call